BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Rugge M, Genta RM, Graham DY, Di Mario F, Vaz Coelho LG, Kim N, Malfertheiner P, Sugano K, Tsukanov V, Correa P. Chronicles of a cancer foretold: 35 years of gastric cancer risk assessment. Gut. 2016;65:721-725. [PMID: 26927528 DOI: 10.1136/gutjnl-2015-310846] [Cited by in Crossref: 39] [Cited by in F6Publishing: 31] [Article Influence: 6.5] [Reference Citation Analysis]
Number Citing Articles
1 Fan Y, Shi Y, Lin Z, Huang X, Li J, Huang W, Shen D, Zhuang G, Liu W. miR-9-5p Suppresses Malignant Biological Behaviors of Human Gastric Cancer Cells by Negative Regulation of TNFAIP8L3. Dig Dis Sci 2019;64:2823-9. [DOI: 10.1007/s10620-019-05626-2] [Cited by in Crossref: 12] [Cited by in F6Publishing: 13] [Article Influence: 4.0] [Reference Citation Analysis]
2 Botezatu A, Bodrug N. Chronic atrophic gastritis: an update on diagnosis. Med Pharm Rep 2021;94:7-14. [PMID: 33629042 DOI: 10.15386/mpr-1887] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
3 Salazar BE, Pérez-Cala T, Gomez-Villegas SI, Cardona-Zapata L, Pazos-Bastidas S, Cardona-Estepa A, Vélez-Gómez DE, Justinico-Castro JA, Bernal-Cobo A, Dávila-Giraldo HA, Benítez-Guerra JC, Valencia-Cárdenas JT, Ospina EJ, Castaño-Llano R, Bravo MM, Cataño-Correa JC, Zabaleta J, Trespalacios-Rangel AA, Cock-Botero AM, Roldán-Pérez MI, Martínez A. The OLGA-OLGIM staging and the interobserver agreement for gastritis and preneoplastic lesion screening: a cross-sectional study. Virchows Arch 2022. [PMID: 35089403 DOI: 10.1007/s00428-022-03286-8] [Reference Citation Analysis]
4 Mescoli C, Gallo Lopez A, Taxa Rojas L, Jove Oblitas W, Fassan M, Rugge M. Gastritis staging as a clinical priority. Eur J Gastroenterol Hepatol. 2018;30:125-129. [PMID: 29215433 DOI: 10.1097/meg.0000000000001015] [Cited by in Crossref: 4] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
5 Lee YC, Lin JT. Screening and Treating Helicobacter pylori Infection for Gastric Cancer Prevention on the Population Level. J Gastroenterol Hepatol. 2017; Jan 14. [Epub ahead of print]. [PMID: 28087975 DOI: 10.1111/jgh.13726] [Cited by in Crossref: 15] [Cited by in F6Publishing: 15] [Article Influence: 3.0] [Reference Citation Analysis]
6 Zhou P, Hao X, Liu Y, Yang Z, Xu M, Liu S, Zhang S, Yang T, Wang X, Wang Y. Determination of the protective effects of Hua-Zhuo-Jie-Du in chronic atrophic gastritis by regulating intestinal microbiota and metabolites: combination of liquid chromatograph mass spectrometer metabolic profiling and 16S rRNA gene sequencing. Chin Med 2021;16:37. [PMID: 33933119 DOI: 10.1186/s13020-021-00445-y] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
7 Rugge M, Meggio A, Pravadelli C, Barbareschi M, Fassan M, Gentilini M, Zorzi M, Pretis GD, Graham DY, Genta RM. Gastritis staging in the endoscopic follow-up for the secondary prevention of gastric cancer: a 5-year prospective study of 1755 patients. Gut 2018;68:11-7. [DOI: 10.1136/gutjnl-2017-314600] [Cited by in Crossref: 54] [Cited by in F6Publishing: 55] [Article Influence: 13.5] [Reference Citation Analysis]
8 Rugge M, Sacchi D, Graham DY, Genta RM. Secondary prevention of gastric cancer: merging the endoscopic atrophic border with OLGA staging. Gut 2020;69:1151-2. [PMID: 31186295 DOI: 10.1136/gutjnl-2019-319107] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 1.3] [Reference Citation Analysis]
9 Yun CY, Kim N, Lee J, Lee JY, Hwang YJ, Lee HS, Yoon H, Shin CM, Park YS, Kim JW, Lee DH. Usefulness of OLGA and OLGIM system not only for intestinal type but also for diffuse type of gastric cancer, and no interaction among the gastric cancer risk factors. Helicobacter. 2018;23:e12542. [PMID: 30303591 DOI: 10.1111/hel.12542] [Cited by in Crossref: 17] [Cited by in F6Publishing: 18] [Article Influence: 4.3] [Reference Citation Analysis]
10 Liu CC, Chen JL, Chang XR, He QD, Shen JC, Lian LY, Wang YD, Zhang Y, Ma FQ, Huang HY, Yang ZB. Comparative metabolomics study on therapeutic mechanism of electro-acupuncture and moxibustion on rats with chronic atrophic gastritis (CAG). Sci Rep 2017;7:14362. [PMID: 29084954 DOI: 10.1038/s41598-017-13195-5] [Cited by in Crossref: 15] [Cited by in F6Publishing: 17] [Article Influence: 3.0] [Reference Citation Analysis]
11 Ajani JA, Lee J, Sano T, Janjigian YY, Fan D, Song S. Gastric adenocarcinoma. Nat Rev Dis Primers. 2017;3:17036. [PMID: 28569272 DOI: 10.1038/nrdp.2017.36] [Cited by in Crossref: 178] [Cited by in F6Publishing: 184] [Article Influence: 35.6] [Reference Citation Analysis]
12 Kim HJ, Kim N, Yun CY, Lee HS. The clinical meaning of the "indefinite for atrophy" lesions within gastric mucosa biopsy specimens in a region with a high prevalence of gastric cancer. Helicobacter 2019;24:e12605. [PMID: 31304663 DOI: 10.1111/hel.12605] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
13 Yoon K, Kim N. Reversibility of Atrophic Gastritis and Intestinal Metaplasia by Eradication of Helicobacter pylori. Korean J Gastroenterol 2018;72:104. [DOI: 10.4166/kjg.2018.72.3.104] [Cited by in Crossref: 4] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
14 Wang Z, Gao X, Zeng R, Wu Q, Sun H, Wu W, Zhang X, Sun G, Yan B, Wu L, Ren R, Guo M, Peng L, Yang Y. Changes of the Gastric Mucosal Microbiome Associated With Histological Stages of Gastric Carcinogenesis.Front Microbiol. 2020;11:997. [PMID: 32547510 DOI: 10.3389/fmicb.2020.00997] [Cited by in Crossref: 17] [Cited by in F6Publishing: 17] [Article Influence: 8.5] [Reference Citation Analysis]
15 Langner C. Vorstufen des Magenkarzinoms: Dysplasie und Adenom. Pathologe 2017;38:67-74. [DOI: 10.1007/s00292-017-0270-4] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 1.0] [Reference Citation Analysis]
16 Rugge M, Dinis-ribeiro M. Letter: gastric atrophy assessment-merging serology, endoscopy and histology in clinical practice. Aliment Pharmacol Ther 2018;47:151-2. [DOI: 10.1111/apt.14383] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.4] [Reference Citation Analysis]
17 Yang JH, Yu K, Si XK, Li S, Cao YJ, Li W, Zhang JX. Liensinine inhibited gastric cancer cell growth through ROS generation and the PI3K/AKT pathway. J Cancer 2019;10:6431-8. [PMID: 31772676 DOI: 10.7150/jca.32691] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 1.7] [Reference Citation Analysis]
18 Negovan A, Iancu M, Fülöp E, Bănescu C. Helicobacter pylori and cytokine gene variants as predictors of premalignant gastric lesions. World J Gastroenterol 2019; 25(30): 4105-4124 [PMID: 31435167 DOI: 10.3748/wjg.v25.i30.4105] [Cited by in CrossRef: 12] [Cited by in F6Publishing: 12] [Article Influence: 4.0] [Reference Citation Analysis]
19 Hoft SG, Noto CN, DiPaolo RJ. Two Distinct Etiologies of Gastric Cancer: Infection and Autoimmunity. Front Cell Dev Biol 2021;9:752346. [PMID: 34900999 DOI: 10.3389/fcell.2021.752346] [Reference Citation Analysis]
20 Fassan M, Saraggi D, Balsamo L, Realdon S, Scarpa M, Castoro C, Coati I, Salmaso R, Farinati F, Guzzardo V, Arcidiacono D, Munari G, Gasparini P, Veronese N, Luchini C, Valeri N, Rugge M. Early miR-223 Upregulation in Gastroesophageal Carcinogenesis. Am J Clin Pathol. 2017;147:301-308. [PMID: 28395057 DOI: 10.1093/ajcp/aqx004] [Cited by in Crossref: 17] [Cited by in F6Publishing: 15] [Article Influence: 3.4] [Reference Citation Analysis]
21 Rugge M, Genta RM, Di Mario F, El-Omar EM, El-Serag HB, Fassan M, Hunt RH, Kuipers EJ, Malfertheiner P, Sugano K, Graham DY. Gastric Cancer as Preventable Disease. Clin Gastroenterol Hepatol. 2017;15:1833-1843. [PMID: 28532700 DOI: 10.1016/j.cgh.2017.05.023] [Cited by in Crossref: 93] [Cited by in F6Publishing: 91] [Article Influence: 18.6] [Reference Citation Analysis]
22 Negovan A, Iancu M, Tripon F, Crauciuc A, Mocan S, Bănescu C. Cytokine TGF-β1, TNF-α, IFN-γ and IL-6 Gene Polymorphisms and Localization of Premalignant Gastric Lesions in Immunohistochemically H. pylori-negative Patients. Int J Med Sci 2021;18:2743-51. [PMID: 34104107 DOI: 10.7150/ijms.60517] [Reference Citation Analysis]
23 Smolka AJ, Schubert ML. Helicobacter pylori-Induced Changes in Gastric Acid Secretion and Upper Gastrointestinal Disease. Curr Top Microbiol Immunol 2017;400:227-52. [PMID: 28124156 DOI: 10.1007/978-3-319-50520-6_10] [Cited by in Crossref: 8] [Cited by in F6Publishing: 12] [Article Influence: 1.6] [Reference Citation Analysis]
24 Rugge M, Genta RM, Fassan M, Valentini E, Coati I, Guzzinati S, Savarino E, Zorzi M, Farinati F, Malfertheiner P. OLGA Gastritis Staging for the Prediction of Gastric Cancer Risk: A Long-term Follow-up Study of 7436 Patients. Am J Gastroenterol. 2018;113:1621-1628. [PMID: 30333540 DOI: 10.1038/s41395-018-0353-8] [Cited by in Crossref: 40] [Cited by in F6Publishing: 40] [Article Influence: 10.0] [Reference Citation Analysis]
25 Urba M, Skieceviciene J, Janciauskas D, Jonaitis L, Kupcinskas L, Fassan M, Rugge M, Kupcinskas J. Gastritis Stages in Monozygotic and Dizygotic Dyspeptic Twins. Gastroenterol Res Pract 2020;2020:9510717. [PMID: 32714389 DOI: 10.1155/2020/9510717] [Reference Citation Analysis]
26 Genta RM. Editorial: the post- Helicobacte r stomach-not the same for cohorts and individuals. Aliment Pharmacol Ther 2018;47:846-7. [DOI: 10.1111/apt.14491] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
27 Tsukanov VV, Kasparov EV, Tonkikh JL, Shtygasheva OV, Butorin NN, Amelchugova OS, Vasyutin AV, Bronnikova EP, Fassan M, Rugge M. Peptic Ulcer Disease and Helicobacter pylori Infection in Different Siberian Ethnicities. Helicobacter 2017;22. [PMID: 27265879 DOI: 10.1111/hel.12322] [Cited by in Crossref: 6] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]
28 Chen X, Dai Y, Zhang Y, Liu F, Lan S, Wang S, Hu L, Li P. Efficacy of traditional Chinese Medicine for gastric precancerous lesion: A meta-analysis of randomized controlled trials. Complementary Therapies in Clinical Practice 2020;38:101075. [DOI: 10.1016/j.ctcp.2019.101075] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
29 Rugge M, Sugano K, Scarpignato C, Sacchi D, Oblitas WJ, Naccarato AG. Gastric cancer prevention targeted on risk assessment: Gastritis OLGA staging. Helicobacter. 2019;24:e12571. [PMID: 30773732 DOI: 10.1111/hel.12571] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 3.3] [Reference Citation Analysis]
30 Bertz S, Angeloni M, Drgac J, Falkeis C, Lang-Schwarz C, Sterlacci W, Veits L, Hartmann A, Vieth M. Helicobacter Infection and Gastric Adenoma. Microorganisms 2021;9:E108. [PMID: 33466325 DOI: 10.3390/microorganisms9010108] [Reference Citation Analysis]
31 Liu W, Fan Y, Shi Y, Lin Z, Huang X, Huang W, Shen D, Qi Z. Knockdown of TIPE2 increases the proliferation in lipopolysaccharide-stimulated gastric cancer cells. BMC Cancer 2018;18:857. [PMID: 30157801 DOI: 10.1186/s12885-018-4761-3] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 0.8] [Reference Citation Analysis]
32 Li Z, Li Y, Jia Y, Ding B, Yu J. Rab1A knockdown represses proliferation and promotes apoptosis in gastric cancer cells by inhibition of mTOR/p70S6K pathway. Arch Biochem Biophys 2020;685:108352. [PMID: 32240637 DOI: 10.1016/j.abb.2020.108352] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
33 Lenti MV, Rugge M, Lahner E, Miceli E, Toh BH, Genta RM, De Block C, Hershko C, Di Sabatino A. Autoimmune gastritis. Nat Rev Dis Primers. 2020;6:56. [PMID: 32647173 DOI: 10.1038/s41572-020-0187-8] [Cited by in Crossref: 21] [Cited by in F6Publishing: 28] [Article Influence: 10.5] [Reference Citation Analysis]
34 Shi Y, Wang P, Guo Y, Liang X, Li Y, Ding S. Helicobacter pylori-Induced DNA Damage Is a Potential Driver for Human Gastric Cancer AGS Cells. DNA Cell Biol 2019;38:272-80. [PMID: 30657337 DOI: 10.1089/dna.2018.4487] [Cited by in Crossref: 10] [Cited by in F6Publishing: 9] [Article Influence: 3.3] [Reference Citation Analysis]
35 Benedetti I, Hoyos J, Barrios L. Cyclooxigenase-2 and osteopontin in gastric pre-neoplastic lesions in relation to H-pylori infection and grade of inflammation. Rev Esp Patol 2020;53:79-87. [PMID: 32199598 DOI: 10.1016/j.patol.2019.06.005] [Reference Citation Analysis]